Summary of Product Characteristics
last updated on the eMC:
21/04/2010
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 21/04/2010 and displayed until Current
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
-
Change to section 10 date of revision of the text
|
| Date of revision of text on the SPC: 05-Mar-2010 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to section 6.5
(1) To register an alternative cap 2-piece HDPE plastic child-resistant cap fitted with a polyterephtalate ethylene faced aluminium/expanded polyethylene laminated wad for the medicinal product as requested by the MHRA.
(2) To register the deletion of obsolete presentations (involving non-CRC caps that are no longer allowable) and pack sizes (30ml) that are no more appropriate are to be removed.
|
|
Updated on 08/06/2009 and displayed until 21/04/2010
|
Reasons for adding or updating:
|
-
Change to section 1 -Name of the Medicinal product
|
| Date of revision of text on the SPC: 27-May-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Registration of an alternative brand name on the licence
|
|
Updated on 12/05/2009 and displayed until 08/06/2009
|
Reasons for adding or updating:
|
-
Change to section 4.1 - Therapeutic indications
-
Change to section 4.2 - Posology and method of administration
-
Change to section 4.3 - Contraindications
-
Change to section 4.4 - Special warnings and precautions for Use
-
Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
-
Change to section 4.8 - Undesirable Effects
|
| Date of revision of text on the SPC: 02-Apr-2009 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Update to Childrens Cough and Cold medicinal products as requested by the MHRA:
http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON038908
|
|
Updated on 21/10/2008 and displayed until 12/05/2009
|
Reasons for adding or updating:
|
-
Introduction of new pack/pack size
|
| Date of revision of text on the SPC: 09-Sep-2008 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
Updated on 21/08/2008 and displayed until 21/10/2008
|
Reasons for adding or updating:
|
-
Change to section 6. 5 - Nature and Contents of Container
|
| Date of revision of text on the SPC: 13-Aug-2008 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| None provided |
|
Updated on 03/04/2008 and displayed until 21/08/2008
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
|
| Date of revision of text on the SPC: 03/2008 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Change to MA as a result of integration
|
|
Updated on 14/09/2006 and displayed until 03/04/2008
|
Reasons for adding or updating:
|
-
Change to section 10 (date of (partial) revision of the text
|
| Date of revision of text on the SPC: 04/2006 |
| Legal Category: GSL |
| Black Triangle (CHM):
NO |
Free-text change information supplied by the pharmaceutical company
|
| Section 10 Change to date of revision of test
|
|
Updated on 30/09/2004 and displayed until 14/09/2006
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
|
|
Updated on 28/09/2004 and displayed until 30/09/2004
|
Reasons for adding or updating:
|
-
Improved Electronic Presentation
-
SPC Submitted in error
|
|
Updated on 29/09/2003 and displayed until 28/09/2004
|
Reasons for adding or updating:
|
-
Change to section 4.2 - Posology and Method of Administration
-
Change to section 4.5 - Interactions with other Medicaments and other forms of Interaction
-
Change to section 5.1 - Pharmacodynamic Properties
-
Change to section 5.2 - Pharmacokinetic Properties
-
Change to section 7 - Marketing Authorisation Holder
|
|
Updated on 19/09/2002 and displayed until 29/09/2003
|
Reasons for adding or updating:
|
-
Change to section 7 - Marketing Authorisation Holder
-
Change to section 10 (date of (partial) revision of the text
|
|
Updated on 29/08/2001 and displayed until 19/09/2002
|
Reasons for adding or updating:
|
-
New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
|
|